semaglutide effects on heart and the Heart: clinical insights from the SELECT Trial Semaglutide dose may matter more – VisualAbstract: Semaglutide Improves Outcomes in

The scientific evidence is unambiguous: body weight is regulated by powerful hormonal, neurological, and metabolic systems that actively resist weight loss and promote weight regain when caloric intake is reduced

After 3 months Semaglutide users lost approximately 9.6% of their body weight as compared to 2.8% in the placebo group

The maintenance dose of WEGOVY is 2.4 mg once weekly OZEMPIC does NOT have a 1.7mg or 2.4mg dosing prefilled pen

GLP-1 analogues, like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide, have garnered attention for their remarkable impact on weight management

Ozempic and Rybelsus are indicated for type 2 diabetes, and Wegovy is FDA-approved for weight management in obese and overweight patients with at least one weight-related condition, when combined with increased physical activity and a reduced-calorie diet

However, large-scale, blinded placebo-controlled trials are lacking